Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson's disease.
Martínez M, Ariz M, Alvarez I, Castellanos G, Aguilar M, Hernández-Vara J, Caballol N, Garrido A, Bayés À, Vilas D, Marti MJ; Catalonian Neuroimaging Parkinson’s disease Consortium; Pastor P, de Solórzano CO, Pastor MA. Martínez M, et al. Among authors: bayes a. NPJ Parkinsons Dis. 2023 Apr 15;9(1):62. doi: 10.1038/s41531-023-00503-2. NPJ Parkinsons Dis. 2023. PMID: 37061532 Free PMC article.
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers.
Pont-Sunyer C, Iranzo A, Gaig C, Fernández-Arcos A, Vilas D, Valldeoriola F, Compta Y, Fernández-Santiago R, Fernández M, Bayés A, Calopa M, Casquero P, de Fàbregues O, Jaumà S, Puente V, Salamero M, José Martí M, Santamaría J, Tolosa E. Pont-Sunyer C, et al. Among authors: bayes a. PLoS One. 2015 Jul 15;10(7):e0132368. doi: 10.1371/journal.pone.0132368. eCollection 2015. PLoS One. 2015. PMID: 26177462 Free PMC article.
Nigral and striatal connectivity alterations in asymptomatic LRRK2 mutation carriers: A magnetic resonance imaging study.
Vilas D, Segura B, Baggio HC, Pont-Sunyer C, Compta Y, Valldeoriola F, José Martí M, Quintana M, Bayés A, Hernández-Vara J, Calopa M, Aguilar M, Junqué C, Tolosa E; the Barcelona LRRK2 Study Group. Vilas D, et al. Among authors: bayes a. Mov Disord. 2016 Dec;31(12):1820-1828. doi: 10.1002/mds.26799. Epub 2016 Sep 21. Mov Disord. 2016. PMID: 27653520 Free article.
MicroRNA Deregulation in Blood Serum Identifies Multiple System Atrophy Altered Pathways.
Pérez-Soriano A, Bravo P, Soto M, Infante J, Fernández M, Valldeoriola F, Muñoz E, Compta Y, Tolosa E, Garrido A, Ezquerra M, Fernández-Santiago R, Martí MJ; Catalan MSA registry (CMSAR). Pérez-Soriano A, et al. Mov Disord. 2020 Oct;35(10):1873-1879. doi: 10.1002/mds.28143. Epub 2020 Jul 20. Mov Disord. 2020. PMID: 32687224
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study).
Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, Mas N, Hofeneder D, Brücke T, Bayés A, Wenzel K, Infante J, Zach H, Pirker W, Posada IJ, Álvarez R, Ispierto L, De Fàbregues O, Callén A, Palasí A, Aguilar M, Martí MJ, Valldeoriola F, Salamero M, Poewe W, Tolosa E. Pont-Sunyer C, et al. Among authors: bayes a. Mov Disord. 2015 Feb;30(2):229-37. doi: 10.1002/mds.26077. Epub 2014 Dec 1. Mov Disord. 2015. PMID: 25449044
Comparison of the Results of a Parkinson's Holter Monitor With Patient Diaries, in Real Conditions of Use: A Sub-analysis of the MoMoPa-EC Clinical Trial.
Pérez-López C, Hernández-Vara J, Caballol N, Bayes À, Buongiorno M, Lopez-Ariztegui N, Gironell A, López-Sánchez J, Martínez-Castrillo JC, Sauco M A, López-Manzanares L, Escalante-Arroyo S, Pérez-Martínez DA, Rodríguez-Molinero A; MoMoPa-EC Research Group. Pérez-López C, et al. Among authors: bayes a. Front Neurol. 2022 May 16;13:835249. doi: 10.3389/fneur.2022.835249. eCollection 2022. Front Neurol. 2022. PMID: 35651347 Free PMC article.
150 results